Neil Morganstein

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
4695 Background: Options for patients with progression of prostate cancer following androgen ablation and chemotherapy are limited. Prior studies have demonstrated the efficacy of estrogen in this(More)
  • 1